Date published: 2026-5-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

CIS Inhibitors

CIS inhibitors, or compounds that inhibit the constitutive activity of certain proteins or pathways, represent a chemically diverse class of molecules that are primarily characterized by their ability to modulate the function of specific enzymes or signaling cascades. These molecules often act by binding to a particular site on a target protein, thereby preventing the protein from adopting its active conformation or from interacting with its usual substrates or cofactors. The specificity of CIS inhibitors typically arises from their structural complementarity to the active or allosteric sites of the target proteins. This complementarity allows them to effectively block or alter the natural activity of the protein, leading to changes in the downstream signaling or metabolic pathways. In many cases, these inhibitors are designed or discovered through high-throughput screening of large chemical libraries, followed by structural optimization to enhance their binding affinity and selectivity. In terms of their chemical nature, CIS inhibitors can range from small organic molecules to more complex structures such as peptides or synthetic analogs. The design of these inhibitors often involves extensive structure-activity relationship (SAR) studies, where modifications to the chemical structure are made to improve their efficacy as inhibitors while minimizing off-target effects. Many CIS inhibitors contain functional groups that are crucial for their binding interactions, such as hydrogen bond donors or acceptors, hydrophobic moieties, or metal-coordinating groups, depending on the nature of the target protein. The development of these inhibitors also involves considerations of their physical and chemical properties, such as solubility, stability, and permeability, which can significantly impact their performance in biological systems. Overall, CIS inhibitors play a crucial role in the study of biological processes, offering insights into the function of specific proteins and the broader pathways in which they are involved.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fludarabine

21679-14-1sc-204755
sc-204755A
5 mg
25 mg
$58.00
$204.00
15
(1)

Targets STAT phosphorylation, potentially modulating CIS-related signaling.

SKI II

312636-16-1sc-204286
sc-204286A
10 mg
50 mg
$96.00
$400.00
3
(2)

Inhibits Protein Inhibitor of Activated STAT, potentially affecting CIS-mediated regulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, potentially affecting pathways that interact with CIS.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, potentially modulating pathways involving CIS.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits various tyrosine kinases, indirectly affecting CIS-related pathways.

Sodium stibogluconate

16037-91-5sc-202815
1 g
$188.00
6
(2)

Inhibits SHP1, potentially influencing CIS function in cytokine signaling.

Pimozide

2062-78-4sc-203662
100 mg
$104.00
3
(1)

Inhibits STAT5, a downstream component of the JAK/STAT pathway, affecting CIS function.